← Browse by Condition
Medical Condition

contraception

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for contraception sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — contraception Clinical Trials

How many clinical trials are currently recruiting for contraception?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for contraception, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for contraception?
contraception research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a contraception clinical trial?
Eligibility criteria for contraception trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Center for Epidemiology and Health Research, Germany 1 trial
University Hospital, Geneva 1 trial
Pakistan Institute of Medical Sciences 1 trial
University of California, San Francisco 1 trial
Yale University 1 trial

Recruiting Clinical Trials

NCT06028555
Recruiting
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety Study
Enrollment
101,000 pts
Location
Germany
Sponsor
Center for Epidemiology and He...
View Trial →
NCT07320651
Recruiting
Improving Shared Decision-Making in Menstrual Management and Contraception for Adolescents and Young Adults
Enrollment
252 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
View Trial →
NCT07271836
Recruiting
PLACE Trial: Preserving Long-Acting Contraception Through Education
Enrollment
900 pts
Location
Pakistan
Sponsor
Pakistan Institute of Medical ...
View Trial →
NCT07301281
Recruiting
Trial of the "Mittin" Intervention to Improve Contraceptive Side Effect Counseling and Follow-up in Ethiopia
Enrollment
2,715 pts
Location
Ethiopia
Sponsor
University of California, San ...
View Trial →
NCT07201402 Phase 2
Recruiting
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Enrollment
62 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07012369
Recruiting
Written and Visual Messages on Sanitary Nap Packagig
Enrollment
50 pts
Location
Turkey (Türkiye)
Sponsor
Ondokuz Mayıs University
View Trial →

Related Conditions

birth control (1) menstrual management (1) side effects (1) attitude (1) knowledge (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology